PACB

$2.44+4.05%visit website

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Market Cap

$758M

Live price × SEC shares (Jul 31, 2026)

Sector

Health Care

Industry

Life Sciences Tools & Services

Beta (raw)

2.21

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

4.8

TTM to Jun 2026 · revenue

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	38,441	44,645	37,178	39,007	159,271
Cost of revenue	22,540	28,079	24,337	26,369	101,325
Gross profit	15,901	16,566	12,841	12,638	57,946
Research & development	22,846	22,879	19,608	23,022	88,355
Selling, general & administrative	31,099	34,051	31,153	33,393	129,696
Total operating expenses	54,778	57,763	21,198	57,248	190,987
Operating income	(38,877)	(41,197)	(8,357)	(44,610)	(133,041)
Interest expense	1,739	1,740	1,740	2,110	7,329
Pretax income	(37,617)	(40,169)	(8,091)	(44,683)	(130,560)
Income tax	383	202	184	58	827
Net income	(38,000)	(40,371)	(8,275)	(44,741)	(131,387)
EPS (basic) ($)	(0.13)		(0.03)	(0.14)	(0.42)
EPS (diluted) ($)	(0.13)		(0.03)	(0.14)	(0.42)
Weighted avg. shares (basic)	300,844		305,819	310,655
Weighted avg. shares (diluted)	300,844		305,819	310,655

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 6, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

11 filings in 12 months · 1 with priority itemsFull history →

Filed	Items	Filing
Aug 5, 2026 accepted 8:23 PM ET	2.02Earnings release2.05Restructuring costs5.02Officer / director change7.01Reg FD disclosure	Document SEC ↗
Jul 9, 2026 accepted 8:32 PM ET	5.02Officer / director change	Document SEC ↗
Jun 4, 2026 accepted 9:19 PM ET	5.02Officer / director change5.07Shareholder vote	Document SEC ↗
May 7, 2026 accepted 8:14 PM ET	2.02Earnings release	Document SEC ↗
Mar 6, 2026 accepted 9:06 PM ET	5.02Officer / director change7.01Reg FD disclosure	Document SEC ↗
Mar 5, 2026 accepted 1:34 PM ET	5.02Officer / director change7.01Reg FD disclosure	Document SEC ↗
Feb 12, 2026 accepted 9:10 PM ET	2.02Earnings release	Document SEC ↗
Feb 3, 2026 accepted 9:20 PM ET	5.02Officer / director change	Document SEC ↗
Feb 2, 2026 accepted 2:25 PM ET	1.01Material agreement2.01Acquisition / disposition7.01Reg FD disclosure	Document SEC ↗
Jan 12, 2026 accepted 2:07 PM ET	2.02Earnings release8.01Other events	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

52%

W/W -13.0pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Velocity Score

5.70x

Avg Daily Selling (90d)

7,653 sh/day

Baseline Daily Selling

3,338 sh/day

Unique Sellers (90d)

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-10-06	2026-10-08	Gibson James R II	See Remarks	Sale	661.8K	$3.11	$2.06M	1.08M	View
2026-08-17	2026-08-18	Van Oene Mark	See Remarks	Sale	26.9K	$1.13	$30K	2.71M	View
2026-04-01	2026-04-03	Gibson James R II	See Remarks	Sale	88.2K	$1.37	$121K	1.25M	View
2026-03-03	2026-03-04	Farmer Michele	See Remarks	Sale	2,979	$1.51	$5K	305.9K	View
2026-03-03	2026-03-04	Van Oene Mark	See Remarks	Sale	6,504	$1.51	$10K	2.24M	View

1–5 of 12

1 / 3

Recent News

PacBio (PACB) reports Q3: everything you need to know ahead of earnings

TradingView · 2026-11-03

Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3

Yahoo · 2026-10-31

Will TXG Stock Ever Get Back To Its Old High?

Yahoo · 2026-10-30

Pacific Biosciences of California (PACB) Rises As Market Takes a Dip: Key Facts

Yahoo · 2026-10-29

Glaukos (GKOS) Q3 Earnings and Revenues Surpass Estimates

Yahoo · 2026-10-28

10 Health Care Stocks Whale Activity In Today’s Session

Benzinga · 2026-10-28

12 Health Care Stocks Moving In Wednesday's Intraday Session

Benzinga · 2026-10-28

Vertiv, Evercore, Brinker, GE HealthCare And Other Big Stocks Moving Higher On Wednesday

Benzinga · 2026-10-28

PacBio to Participate in Upcoming Investor Conferences

Yahoo · 2026-10-27

Here's Why You Should Hold PacBio Stock in Your Portfolio for Now

Yahoo · 2026-10-27

1 of Wall Street’s favorite stocks worth your attention and 2 we turn down

Yahoo · 2026-10-27

Pacific Biosciences of California (PACB) Declines More Than Market: Some Information for Investors

Yahoo · 2026-10-22

PacBio and Verily Health Announce Multi-Year Strategic Collaboration to Scale Long-Read Genomics for Biomedical AI

Yahoo · 2026-10-19

PacBio to Report Third Quarter 2026 Financial Results on November 4, 2026

Yahoo Finance · 2026-10-14

PacBio Teams With TychoBio to Advance AI-Driven RNA Therapeutics

Yahoo Finance · 2026-10-13

Informational purposes only, not investment advice.

PACB

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

Reporting Insiders

Factor Profile

Corporate Events (8-K)

Date	Insider	Type	Shares	Value
2026-10-06	Gibson James R II	S	661,815	$2M
2026-08-17	Van Oene Mark	S	26,911	$30,409.43
2026-04-01	Gibson James R II	S	88,185	$120,813.45
2026-03-03	Farmer Michele	S	2,979	$4,510.21
2026-03-03	Van Oene Mark	S	6,504	$9,847.06